So far, CRM has already been applied in AD to study the impact of filaggrin mutations [59,60,61], to compare sensitive skin with atopic and non-sensitive skin [62], to compare HS with lesional atopic and psoriatic skin [63], and to create an objective classification score for AD [64]. Here, FLG is linked to Alzheimer disease.